palmitoylcarnitine and sphingosine phosphorylcholine

palmitoylcarnitine has been researched along with sphingosine phosphorylcholine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fonfria, E; Michel, AD	1

Other Studies

1 other study(ies) available for palmitoylcarnitine and sphingosine phosphorylcholine

Article	Year
Agonist potency at P2X7 receptors is modulated by structurally diverse lipids. British journal of pharmacology, 2007, Volume: 152, Issue:4 Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Dose-Response Relationship, Drug; Ethidium; Fluorometry; Humans; Interleukin-1beta; Lipids; Lysophosphatidylcholines; Mice; Octoxynol; Palmitoylcarnitine; Phosphorylcholine; Purinergic P2 Receptor Agonists; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X7; Sphingosine; Surface-Active Agents	2007

Article

Year

Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

British journal of pharmacology, 2007, Volume: 152, Issue:4

Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Dose-Response Relationship, Drug; Ethidium; Fluorometry; Humans; Interleukin-1beta; Lipids; Lysophosphatidylcholines; Mice; Octoxynol; Palmitoylcarnitine; Phosphorylcholine; Purinergic P2 Receptor Agonists; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X7; Sphingosine; Surface-Active Agents

2007